Homepage
Author:
Century Therapeutics, Inc.
Posted Date:
June 8, 2026
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
Century Therapeutics, Inc.
June 8, 2026
Century Therapeutics Reports First Quarter Financial Results and Business Updates
Century Therapeutics, Inc.
May 13, 2026
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
Century Therapeutics, Inc.
April 30, 2026
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
Century Therapeutics, Inc.
March 12, 2026
Century Therapeutics to Participate in Upcoming Investor Conferences in March
Century Therapeutics, Inc.
February 25, 2026
